Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration has approved two Ortho Clinical Diagnostics assays for diagnosing hepatitis B infection in individuals with acute or chronic hepatitis B, or who are recovering from hepatitis B infection, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.